205 related articles for article (PubMed ID: 23119236)
1. Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride.
Mandal S; Thimmasetty MK; Prabhushankar G; Geetha M
Int J Pharm Investig; 2012 Apr; 2(2):78-82. PubMed ID: 23119236
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of in-situ gel for ophthalmic formulation containing ciprofloxacin hydrochloride.
Makwana SB; Patel VA; Parmar SJ
Results Pharma Sci; 2016; 6():1-6. PubMed ID: 26949596
[TBL] [Abstract][Full Text] [Related]
3. Sustained ocular delivery of brimonidine tartrate using ion activated in situ gelling system.
Geethalakshmi A; Karki R; Jha SK; Venkatesh DP; Nikunj B
Curr Drug Deliv; 2012 Mar; 9(2):197-204. PubMed ID: 22283647
[TBL] [Abstract][Full Text] [Related]
4. Formulation and evaluation of micro hydrogel of Moxifloxacin hydrochloride.
Nanjwade BK; Deshmukh RV; Gaikwad KR; Parikh KA; Manvi FV
Eur J Drug Metab Pharmacokinet; 2012 Jun; 37(2):117-23. PubMed ID: 22015966
[TBL] [Abstract][Full Text] [Related]
5. Terminalia arjuna gum/alginate in situ gel system with prolonged retention time for ophthalmic drug delivery.
Noreen S; Ghumman SA; Batool F; Ijaz B; Basharat M; Noureen S; Kausar T; Iqbal S
Int J Biol Macromol; 2020 Jun; 152():1056-1067. PubMed ID: 31751751
[TBL] [Abstract][Full Text] [Related]
6. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept.
Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M
Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613
[TBL] [Abstract][Full Text] [Related]
7. Studies on In situ Hydrogel: A Smart Way for Safe and Sustained Ocular Drug Delivery.
Shastri D; Patel L; Parikh R
J Young Pharm; 2010 Apr; 2(2):116-20. PubMed ID: 21264112
[TBL] [Abstract][Full Text] [Related]
8. Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time.
Destruel PL; Zeng N; Seguin J; Douat S; Rosa F; Brignole-Baudouin F; Dufaÿ S; Dufaÿ-Wojcicki A; Maury M; Mignet N; Boudy V
Int J Pharm; 2020 Jan; 574():118734. PubMed ID: 31705970
[TBL] [Abstract][Full Text] [Related]
9. Preparation and evaluation of nanoparticles loaded ophthalmic in situ gel.
Kesarla R; Tank T; Vora PA; Shah T; Parmar S; Omri A
Drug Deliv; 2016 Sep; 23(7):2363-2370. PubMed ID: 25579467
[TBL] [Abstract][Full Text] [Related]
10. Formulation and evaluation of voriconazole ophthalmic solid lipid nanoparticles in situ gel.
Pandurangan DK; Bodagala P; Palanirajan VK; Govindaraj S
Int J Pharm Investig; 2016; 6(1):56-62. PubMed ID: 27014620
[TBL] [Abstract][Full Text] [Related]
11. Design and Development of Thermoreversible Ophthalmic In Situ Hydrogel of Moxifloxacin HCl.
Shastri DH; Prajapati ST; Patel LD
Curr Drug Deliv; 2010 Jul; 7(3):238-43. PubMed ID: 20497100
[TBL] [Abstract][Full Text] [Related]
12. Ion-activated In Situ Gelling Ophthalmic Delivery Systems of Azithromycin.
Vijaya C; Goud KS
Indian J Pharm Sci; 2011 Nov; 73(6):615-20. PubMed ID: 23112394
[TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of a novel in situ gel of sparfloxacin for sustained ocular drug delivery: in vitro and ex vivo characterization.
Khan N; Aqil M; Imam SS; Ali A
Pharm Dev Technol; 2015; 20(6):662-9. PubMed ID: 24754411
[TBL] [Abstract][Full Text] [Related]
14. Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system.
Gupta H; Jain S; Mathur R; Mishra P; Mishra AK; Velpandian T
Drug Deliv; 2007 Nov; 14(8):507-15. PubMed ID: 18027180
[TBL] [Abstract][Full Text] [Related]
15. Optimizing ophthalmic delivery of a poorly water soluble drug from an aqueous in situ gelling system.
Senjoti FG; Timmins P; Conway BR; Smith AM
Eur J Pharm Biopharm; 2020 Sep; 154():1-7. PubMed ID: 32599271
[TBL] [Abstract][Full Text] [Related]
16. Formulation and evaluation of in situ gelling thermoreversible mucoadhesive gel of fluconazole.
Gonjari ID; Hosmani AH; Karmarkar AB; Godage AS; Kadam SB; Dhabale PN
Drug Discov Ther; 2009 Feb; 3(1):6-9. PubMed ID: 22495461
[TBL] [Abstract][Full Text] [Related]
17. Preparation of levofloxacin loaded
Jain P; Jaiswal CP; Mirza MA; Anwer MK; Iqbal Z
Drug Dev Ind Pharm; 2020 Jan; 46(1):50-56. PubMed ID: 31818154
[TBL] [Abstract][Full Text] [Related]
18. Studies on Poloxamer Based Mucoadhesive Insitu Ophthalmic Hydrogel of Moxifloxacin HCL.
Shastri DH; Prajapati ST; Patel LD
Curr Drug Deliv; 2010 Feb; ():. PubMed ID: 20158483
[TBL] [Abstract][Full Text] [Related]
19. Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin.
Liu Z; Li J; Nie S; Liu H; Ding P; Pan W
Int J Pharm; 2006 Jun; 315(1-2):12-7. PubMed ID: 16616442
[TBL] [Abstract][Full Text] [Related]
20. Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies.
Ranch KM; Maulvi FA; Naik MJ; Koli AR; Parikh RK; Shah DO
Int J Pharm; 2019 Jan; 554():264-275. PubMed ID: 30423418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]